Out of 60,680 patients with skin of color, eight were diagnosed with melanoma, with two considered high risk.
2023
Histologic margin status can help predict lentigo maligna melanoma recurrence
Histologic margin status is a predictor of lentigo maligna melanoma progression.
Contribution of MEK Inhibition to Combined BRAF/MEK Inhibitor Treatment in Advanced BRAF-Mutant Melanoma
In part 2 of a phase III trial (COLUMBUS) reported in the Journal of Clinical Oncology, Paolo A. Ascierto, MD, and colleagues found evidence that MEK inhibition contributed to positive outcomes with combination BRAF/MEK inhibitor therapy in advanced BRAF V600–mutant melanoma.
Melanoma Canada wants to save Canadians’ skin, literally
Melanoma Canada is aiming to educate beachgoers about the staggering statistics surrounding its namesake disease with a new playful campaign that carries a sobering message: “There’s no such thing as a safe tan.”